focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 372.80
Bid: 372.20
Ask: 372.80
Change: -0.80 (-0.21%)
Spread: 0.60 (0.161%)
Open: 371.80
High: 374.20
Low: 371.80
Prev. Close: 373.60
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QinetiQ Group plc Fourth Quarter Trading Update

16 Apr 2024 07:00

RNS Number : 7067K
QinetiQ Group plc
16 April 2024
 

News release

QinetiQ Group plc

Fourth Quarter Trading Update

16 April 2024 - QinetiQ Group plc ("QinetiQ" or the "Group") today issues a trading update covering its fourth quarter to 31 March 2024.

On-track to deliver FY24 expectations

The Group has delivered good operational performance during the fourth quarter, with continued strong organic revenue growth and stable operating profit margin. As a result, we expect our results for the full year to 31 March 2024 to be in line with current market expectations[1].

Order intake for the year has been excellent at more than £1.7bn achieving a book-to-bill of 1.1x, demonstrating the continued high demand for our distinctive offerings. Cash performance in the second half has been particularly strong resulting in cash conversion of more than 100% for the full year, supporting our disciplined capital allocation policy focused on enhancing shareholder returns. The £100m share buyback programme announced in January 2024 is progressing well with 6 million shares purchased to-date at a cost of £22 million.

Throughout the fourth quarter we have seen a continuation of the trends identified in our Interim Results and Q3 Trading Update across each of our reporting segments - EMEA Services has performed particularly well with strong revenue growth offsetting lower Global Solutions revenue growth.

Stronger performance in EMEA Services

EMEA Services has delivered excellent revenue growth in FY24, due to successful programme execution of strong order intake and backlog from the prior year, and our large long-term contracts of Engineering Delivery Partner (EDP) and Weapons Sector Research Framework (WSRF) performing particularly well.

Slower growth in Global Solutions

Global Solutions continued to be impacted by difficult market conditions in the US. As a consequence, Avantus achieved modest revenue growth in the second half compared to the first half. However, the business delivered double digit operating profit margin and strong cash conversion of circa 100%. We are also pleased that the business secured $977m of total contract awards during the year, achieving a funded book-to-bill of 1.2x, with major programme wins aligned to national defence and security priorities. This provides good revenue visibility for FY25 and underpins our continued confidence in the medium and long-term outlook for the business.

Expecting FY25 to be another strong year of growth

Looking forward, we expect FY25 to be another strong year at Group level and we remain on-track to deliver in line with our longer-term guidance. The trends that we have seen in FY24 are expected to continue into next year, with stronger growth in EMEA Services and stable performance in Global Solutions in FY25.

Steve Wadey, Group Chief Executive Officer said:

"During the fourth quarter we have continued to deliver against our strategy and driven good revenue growth and stable operating profit margin. We have had a particularly strong period in EMEA Services, thanks to excellent contract delivery across our programmes, and we expect further strong growth in this segment. The performance of Global Solutions has been impacted by ongoing market conditions in the US. However, the strong order intake in Avantus provides confidence in our platform for future growth.

With a clear focus on disciplined execution of our strategy, high demand for our distinctive offerings and the good progress we have made this year, we have a robust plan to deliver long-term sustainable growth and compelling value for our shareholders."

FY24 Preliminary Results

QinetiQ will publish its full Preliminary Results on Thursday 23 May 2024. We will be hosting an in-person results presentation at 09:30 BST at the London Stock Exchange, 10 Paternoster Square, London, EC4M 7LS. To register to join in-person or via the live webcast:

https://www.qinetiq.com/en/investors/results-reports-and-presentations/fy24-prelim-results

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

John Haworth, Group Director Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications (Media enquiries) +44 (0) 7793 427582

 


[1] Average consensus as at 15/04/24: £1,877m revenue, £211m operating profit

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIASFIELIS
Date   Source Headline
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.